SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932440-16-000335
Filing Date
2016-02-16
Accepted
2016-02-16 16:11:55
Documents
1
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTD.RIDGEBACK CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sch13g-a_4252362.htm SC 13G/A 100402
  Complete submission text file 0000932440-16-000335.txt   101978
Mailing Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011
Business Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011 212-808-7729
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G/A | Act: 34 | File No.: 005-88719 | Film No.: 161428259
SIC: 2834 Pharmaceutical Preparations